Skip to content

Accelerated Pharma, Inc.

CIK 0001630970

← back to feed
Revenue (TTM)
—
Q3 Apr 2020
Net Income (TTM)
—
Q3 Apr 2020
EPS Diluted (TTM)
—
Q3 Apr 2020
Gross Margin
—
Q3 Apr 2020
Operating Margin
—
Q3 Apr 2020
Net Margin
—
Q3 Apr 2020
Free Cash Flow (TTM)
—
Q3 Apr 2020
Cash
—
Q3 Apr 2020
Total Debt
—
Q3 Apr 2020
Shares Outstanding
4.23M sh
Q3 Apr 2020

Recent filings